Lirio Expands Its Proven Behavioral Science and Agentic AI Platform to Life Sciences, Bridging the Gap Between Data and Real-World Behavior

Lirio, the first-ever behavioral science and agentic AI platform that empowers people to live their healthiest lives, today announced the launch of its solution, Precision Nudging® for Life Sciences, developed to help pharmaceutical and biotechnology companies deliver adaptive, behaviorally informed messaging directly to patients and caregivers across every stage of the treatment journey.

As federal regulations tighten around traditional patient outreach methods and more life sciences companies adopt direct-to-consumer models, the responsibility of patient engagement, including medication adherence, is increasingly shifting to individual brands. With its new product offering, Lirio is expanding its proven n-of-1 approach to enhancing patient engagement beyond care delivery, helping life sciences teams meet the growing demand for real-world impact, including higher treatment initiation, stronger adherence, and improved patient outcomes.

“We are at an inflection point where outreach rules are becoming stricter, patients are choosing brands that make their experience easier, and payers are focusing on outcomes instead of impressions. At the same time, privacy changes and the unbundling of care are making direct, consent-based relationships essential. As life sciences organizations embrace new direct-to-patient models, AI-driven behavioral science is the critical bridge between compliant communication and value-creating patient engagements,” said Barbara Salami, former VP of Commercial Excellence and Innovation at Novo Nordisk. “It learns what each patient needs next, adapts with empathy, records every decision for auditability, and turns communication into outcomes such as faster starts, fewer drop-offs, and more confident care journeys.”

Powered by its unique combination of behavioral science and agentic AI, Lirio’s new Life Sciences solutions help organizations deliver deep personalization across every stage of the patient journey. Precision Nudging enables life sciences teams to:

• Boost adherence and persistence by identifying and addressing behavioral barriers that prevent patients from starting or staying on therapy.
• Enhance patient and hub support programs through automated, omnichannel nudges that guide patients and caregivers through enrollment, access, and financial assistance.
• Advance chronic care management by sustaining long-term engagement for patients managing ongoing therapies.
• Accelerate recruitment and improve retention with personalized consent and enrollment messaging that builds trust and reduces drop-off.
• Deepen HCP engagement with adaptive outreach tailored to each provider’s needs and their patients' motivations.

Together, these capabilities help life sciences organizations better understand and move the patients they serve—translating behavioral insight into measurable clinical, operational, and financial outcomes.

“Despite record investments in technology and solutions to improve pharma marketing and hub programs, many patients still don’t start or stay on a therapy or medication,” said Amy Bucher, PhD, Chief Behavioral Officer at Lirio. “This comes down to patients’ unique mix of barriers, like not understanding what’s being prescribed, not trusting it, not being able to afford it, or struggling to make the lifestyle changes that maximize therapy outcomes. With this new offering, we’re helping life sciences teams empower their patients, utilizing best-in-class behavioral science insights to personalize their approach and give patients the best chance for success.”

Lirio’s Chief Behavioral Officer, Amy Bucher, PhD, will be presenting “Precision Adherence: Personalizing the Patient Journey with Agentic AI and Behavioral Science” at the Reuters Pharma Customer Engagement conference in Philadelphia on Wednesday, October 29th.

About Lirio

Lirio is the first-ever behavioral science and agentic AI platform that empowers people to live their healthiest lives through hyper-personalized and empathetic consumer experiences that meaningfully improve outcomes. The company’s proprietary Precision Nudging® Interventions are designed to overcome specific barriers and move people to take action for better health. Lirio has received multiple awards for its excellence in applied artificial intelligence, was named an Inc. Magazine Best Workplace, and is HITRUST® CSF certified, SOC 2 Type II compliant, and NIST certified. For more information, visit www.Lirio.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251028738199/en/